Adicet Bio ACET
NASDAQ ACET
$6.64 -0.50 (-7.00%)
At close: Oct 1, 2026 · 4:00 PM EDT

Adicet Bio (ACET) Capital Leases (2025 - 2026)

Updated

Adicet Bio (ACET) reported Capital Leases of $626,000 for Q2 2026, down 27.0% from the prior quarter.

Analysis

Adicet Bio (ACET) Capital Leases (2025 - 2026) Analysis & Trends

At the end of FY2025, Adicet Bio posted Capital Leases of $642,000.

  • Five-year quarterly Capital Leases spans a low of $626,000 in Q3 2025 and a high of $858,000 in Q1 2026.
  • Per Business Quant data, the three quarters before Q2 2026 came in at $858,000 (Q1 2026), $642,000 (Q4 2025) and $626,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Adicet Bio 66.84 Mn -450.57 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 626,000.00
Mar 31, 2026 858,000.00
Dec 31, 2025 642,000.00
Sep 30, 2025 626,000.00
API Access

Adicet Bio Capital Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-leases&ticker=ACET&period=max&api_key=YOUR_API_KEY